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co-localization of AQP-4 and inward rectifier Kþ channels Kir 4.1, a functional coupling between
these proteins has been proposed. AQP-4 has a putative role in the physiopathology of brain
disorders including epilepsy and trauma. S100B is a calcium-binding protein expressed and
secreted by astrocytes, and commonly used as a parameter of astroglial activation. Here, we
investigate a possible link between AQP-4 activity (and Kir 4.1) and S100B secretion in
hippocampal slices of rats of different ages using non-specific inhibitors of AQP-4 (AZA,
acetazolamide and TEA, tetraethylammonium) and Kir 4.1 (barium chloride). We found that
blockade of AQP-4 with TEA and AZA produced an increase in S100B secretion in young rats,
compatible with an astroglial activation observed in many conditions of brain injury. On the
other hand, BaCl2 induced Kir 4.1 inhibition caused a decrease in S100B secretion. Both
channels, AQP-4 and Kir 4.1, exhibited a similar ontogenetic profile, in spite of the functional
uncoupling, in relation to S100B secretion. Moreover, we found a significant increase in the
S100B secretion basal levels with the increasing of animal age and the incubation with high
levels of potassium resulted in a decrease of S100B secretion in 30 and 90-day old rats. These
data, together with previous observations from gap junctions and glutamate transport of
astrocytes, contribute to characterize the operational system involving astroglial activation,
particularly on S100B secretion, in brain disorders.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.65
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Aquaporin-4 (AQP-4) is the principal brain water channel, and
is predominantly expressed in astrocytes and ependimal
cells. The elevated expression of AQP-4 in astrocytessurrounding synapses and capillary vessels suggests its
dynamic involvement in water homeostasis in the brain
tissue (Medici et al., 2011). This aquaporin has gained much
attention due to its putative role in the physiopathology of
brain disorders including ischemia, epilepsy and traumatic
Fig. 1 – Effect of TEA on S100B secretion in hippocampal
slices. Hippocampal slices fromWistar rats of different ages
(15, 30, 45, 60 and 90-days old) were exposed to TEA at
concentrations of 10 lM (A) and 1000 lM (B) for 1 h. S100B
was determined by ELISA. The line indicates basal secre-
tion, assumed as 100%, in each experiment. Each value is a
mean (7 standard error) of 6 independent experiments
performed in triplicate.  Significantly different from basal
secretion po0.05 compared to control (ANOVA followed by
the Tukey’s test).
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 4 – 2 2 15brain disease, tumor-induced brain swelling, infections and
hydrocephalus (Papadopoulos and Verkman, 2007).
Due to the co-localization between the AQP-4 and potassium
channels, particularly subtype 4.1 of the inwardly rectifier Kþ
channels (Kir 4.1), a functional coupling between these proteins
has been proposed (e.g. Nagelhus et al., 2004). Astrocytes express
multiple Kir channel subtypes; however, Kir 4.1 is predominantly
expressed in these cells and it seems to be the primary
mechanism in maintaining the extracellular Kþ homeostasis
needed for sustained neuronal excitability (Ohno et al., 2007).
There is some evidence of the coupling between Kir 4.1 and AQP-
4. For example, a mislocalization of AQP-4 in transgenic mice
was accompanied by a delayed Kþ clearance (Amiry-
Moghaddam et al., 2003). In spite of this close functionality, the
mechanism that allows an interaction between these channels
remains poorly understood. Moreover, the coupling between
these channels was not found in cultured hippocampal astro-
cytes (Zhang and Verkman, 2008).
Three years ago, it was proposed that S100B, a calcium-binding
protein also expressed in astrocytes, could modulate the expres-
sion of AQP-4 (Esposito et al., 2008). S100B is a very soluble
protein of 21 kDa (Donato et al., 2009). Intracellularly, many
putative protein targets of S100B have been characterized,
particularly modulating cytoskeleton plasticity and cell prolifera-
tion. At sub-nanomolar concentrations, extracellular S100B sti-
mulates in vitro neurite growth, glial proliferation and promotes
neuronal survival. However, elevated levels of this protein
(particularly in cerebrospinal fluid and serum) have been asso-
ciated with astroglial activation in conditions of brain injury
(Goncalves et al., 2008). Although the mechanism of S100B
secretion remains unknown, some secretagogues [e.g. gap-
junction inhibitors (Leite et al., 2009)] have been identified in
glial cell cultures and acute brain slices and these help us to
interpret changes in the extracellular content of this protein.
Beyond the data suggesting an AQP-4-induced expression by
S100B (Esposito et al., 2008), other clues reinforce a putative
connection between S100B and AQP-4. For example, interleukin
1-beta increases the expression of AQP-4 (Ito et al., 2006) and it is
able to modulate S100B secretion in astrocytes and hippocampal
slices (de Souza et al., 2009). Interestingly, in neuromyelitis optica
(NMO), a severe auto-immune demyelinating disease, in which
anti-AQP-4 antibodies are produced (Jarius et al., 2008), an
increase in cerebrospinal fluid S100B was observed in relapsing
patients (Misu et al., 2009). However, no data are available
regarding any direct connection between AQP-4 (or its co-
operant channel Kir 4.1) and S100B secretion.
Herein, we investigated whether changes in AQP-4 and/or
Kir 4.1 activity, using non-specific inhibitors of these chan-
nels, could modulate S100B secretion in hippocampal slices,
and whether such modulation would be related to the age-
dependent expression of these channels. Moreover, we
observed the ontogenetic profile of S100B secretion and the
changes on S100B secretion in hippocampal slices when
incubated with high levels of potassium.2. Results
As shown in Fig. 1, hippocampal slices from 15 or 30-days old
rats incubated with AQP4 inhibitor, TEA, at 10 (Fig. 1A) or1000 mM (Fig. 1B) demonstrated an increase in S100B secre-
tion. However, S100B secretion from hippocampal slices of
older animals (45, 60 or 90-days old rats) was not affected by
the presence of this inhibitor. The integrity and viability of
these slices were evaluated by LDH and MTT reduction
activity assays, respectively (data not shown).
Using AZA, another inhibitor of AQP4, we also observed an
increase in S100B secretion (Fig. 2). At 1 mM AZA, S100B secretion
significantly increased only in hippocampal slices of 15-day old
rats (Fig. 2A). However, at 100 mM AZA, the increase in S100B
secretion was observed in 15, 30 and 45-days old rats (Fig. 2B). It
is important to mention that DMSO at 0.01%, the vehicle for
AZA, did not alter the basal S100B secretion at any age analyzed
(data not shown).
Due to the functional connection between AQP4 and potas-
sium channels, we investigated a possible effect of barium on
S100B secretion in hippocampal slices of rats of different ages
(Fig. 3). When hippocampal slices were incubated with 100 mM
barium chloride, we observed a decrease in S100B secretion in
the younger rats (15 to 45-days old rats) (Fig. 3A). However, at
1000 mM, barium was able to decrease S100B secretion in the
hippocampal slices of rats at all ages analyzed (Fig. 3B).
We then investigated the effects of both TEA (positive
effect) and barium chloride (negative effect) on S100B secre-
tion (Fig. 4). When TEA (at 10 mM) and barium chloride (also at
Fig. 2 – Effect of AZA on S100B secretion in hippocampal
slices. Hippocampal slices fromWistar rats of different ages
(15, 30, 45, 60 and 90-days old) were exposed to AZA at
concentrations of 1 lM (A) and 100 lM (B) for 1 h. S100B was
measured by ELISA. The line indicates basal secretion,
assumed as 100%, in each experiment. Each value is a mean
(7standard error) of 6 independent experiments performed
in triplicate.  Significantly different from basal secretion
po0.05 compared to control (ANOVA followed by the
Tukey’s test).
Fig. 3 – Effect of BaCl2 on S100B secretion in hippocampal
slices. Hippocampal slices fromWistar rats of different ages
(15, 30, 45, 60 and 90-days old) were exposed to BaCl2 at
concentrations of 100 lM (A) and 1000 lM (B) for 1 h. S100B
was measured by ELISA. The line indicates basal secretion,
assumed as 100%, in each experiment. Each value is a mean
(7standard error) of 6 independent experiments performed
in triplicate.  Significantly different from basal secretion
po0.05 compared to control (ANOVA followed by the
Tukey’s test).
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 4 – 2 21610 mM) were administered, an increase of S100B secretion was
observed only in hippocampal slices of 15-day old rats
(Fig. 4A). However, when hippocampal slices were incubated
TEA (at 10 mM) and barium chloride at 1000 mM, the negative
effect on S100B secretion was predominant and observed for
all ages analyzed (Fig. 4B).
In order to evaluate the immunoreactivity for AQP4 and Kir
4.1, we carried out an AQP4 and Kir 4.1 immunohistochemical
study. The photomicrographs of AQP4 and Kir 4.1 indicate the
immunofluorescence for these proteins (Fig. 5A, B, D and E)
and when we analyzed these images by confocal microscopy,
we observed the co-localization of AQP4 and Kir 4.1 in an
astrocyte (Fig. 5C and E). When we analyzed the expression
from these proteins in hippocampi from 15 and 90-day old
rats, we found a similar distribution pattern in young and
adult rats (Fig. 6).
Subsequently, we quantified by western blotting the immu-
nocontent for these proteins in rats of 15, 30, 60 and 90 days
old. We observed a decrease in AQP4 expression in 90-day old
rats when compared with the younger animals (Fig. 7A). The
immunocontent for Kir 4.1 was decreased in 30, 60 and 90-
day old rats, compared with 15-day old animals (Fig. 7B).
Fig. 8 Due the changes in the main potassium channel
present in astrocytes (kir 4.1) during the development and the
possible connection between potassium and S100B, two-wayANOVA was conducted to investigate the S100B secretion in
hippocampal slices from 15, 30 and 90-day old rats when
exposed to a high concentration of potassium. We observed
the significant interaction between treatment and age, thus
we performed the simple main effect test. The high potas-
sium concentration incubated in hippocampi of 15-day old
animals promoted a tendency of increase in S100B secretion
when compared with the control. So, when we used slices
from 30 and 90-day old animals, the incubation with high
potassium resulted in a decrease of S100B secretion. More-
over, we observed a significant increase the S100B secretion
basal levels with the increasing of animal age.3. Discussion
Aquaporin-4, the main water channel of astrocytes, is loca-
lized in the plasmatic membrane surrounding capillaries and
synapses, and is a key component in the pathogenesis of
brain edema, commonly associated with ischemic and trau-
matic brain injury (Perez et al., 2007). During acute transient
arterial occlusion in rats, a rapid loss (about 2 h) of AQP-4 was
observed in a specific area of vascular damage (Friedman
et al., 2009). Other studies in trauma models of brain injury
Fig. 4 – Effect of TEAþBaCl2 on S100B secretion in hippo-
campal slices. Hippocampal slices from Wistar rats of
different ages (15, 30, 45, 60 and 90-days old) were exposed
to TEA and BaCl2 at concentrations of 10 lM (A) and 1000 lM
(B) for 1 h. S100B was measured by ELISA. The line indicates
basal secretion, assumed as 100%, in each experiment. Each
value is a mean (7standard error) of 6 independent
experiments performed in triplicate.  Significantly differ-
ent from basal secretion po0.05 compared to control
(ANOVA followed by the Tukey’s test).
Fig. 5 – Immunohystochemistry for AQP-4 and Kir 4.1. Dent
analyzed by immunohistochemistry for AQP-4 (A and D) and K
immunofluorescence for AQP-4, Kir 4.1 and AQP-4þKir 4.1 (C an
and C panels indicate blood vessels, which are detailed in pane
panels C and F.
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 4 – 2 2 17also showed a decrease in AQP-4, followed by an increase in
this protein (e.g. Ke et al., 2001). Apparently this initial
decrease could reflect a mechanism of self-protection avoid-
ing the brain swelling (Friedman et al., 2009). On the other
hand, the recovery of brain tissue seems to involve the
up-regulation of AQP-4 observed later on.
Commonly, many clinical and experimental conditions of
brain injury are accompanied by elevation of peripheral
S100B, which in turn are interpreted as being due to the
astroglial activation (Goncalves et al., 2008). In fact, acute
S100B release could work as a neurotrophic factor to neighbor
cells (Donato et al., 2009) and/or as an alarmin, i.e., a warning
signal of danger (Bianchi et al., 2007). However, to date, no
direct link between the decrease in AQP-4 function and the
increase in extracellular S100B has been investigated. Our
results in hippocampal slices from young rats show that a
decrease in AQP-4 activity (induced by non-specific inhibi-
tors) was accompanied by an increase in S100B secretion. An
initial increase of S100B in brain injury has been proposed not
only as a warning signal for newborn cells, but also as a
factor released for protection and neural survival (Donato
et al., 2009; Goncalves et al., 2010). Therefore, we may
suppose that S100B release from astrocytes, at least in part,
could result from decreased AQP-4 activity. The mechanism
involved in the S100B secretion is unclear, as well as the
signaling involved. However, the interaction maybe involve a
calcium-mediated signaling pathway initiated by water influx
through the AQP-4 (Thrane et al., 2011), assuming that S100B
secretion seems to be an event that is dependent on calcium
(Davey et al., 2001; Nardin et al., 2009).
In this study, we used two classes of aquaporin-4 inhibi-
tors: TEA (from a class of quaternary ammonium salts) and
AZA (a sulfonamide) (Haddoub et al., 2009). These are non-ate gyrus of hippocampal sections of 30-day old rats were
ir 4.1 (B and E). Panels A, B and C are photomicrographs of
d F, double immunostaining), respectively. Arrows in A, B
ls D, E and F, respectively. Scale bars¼50 lm are indicated in
Fig. 6 – Immunohystochemistry for AQP-4 and Kir 4.1 in 15 and 90-day old rats Dentate gyrus of hippocampal sections of rats
were analyzed by immunohistochemistry for AQP-4 (A and C) and Kir 4.1 (B and D). Panels A and C are photomicrographs of
immunofluorescence for AQP-4 and panels B and D for Kir 4.1. The panels A and B represent 15-day old rats and panels C
and D, 90-day old rats. Scale bars¼50 lm are indicated in panel D.
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 4 – 2 218specific inhibitors for aquaporin-4 inhibitors. Currently, there
are no specific inhibitors for aquaporins and transgenic
animals have been used try to overcome this problem [e.g.
(Tamma et al., 2012)]. TEA is able to inhibit aquaporins sub-
types 1, 2 and 4, but not 3 and 5 at low concentrations
(1–10 mM) (Detmers et al., 2006). Although these compounds
are active inhibitors for sub-type 4 aquaporin (found in
astrocytes), molecular targets other than aquaporins have
been described for these compounds (Huber et al., 2009).
Notice that TEA has an IC50 of 9.8 mM for AQP-4 (Detmers
et al., 2006) and, under our conditions (at 10 and 1000 mM),
this compound stimulated S100B secretion. It has been
reported that TEA, at concentrations of higher than 1 mM,
is able to inhibit Kþ channels (Detmers et al., 2006). However,
when we blocked Kþ channels using BaCl2 a decrease in
S100B secretion was observed.
AZA has an apparent IC50 of 0.9 mM for AQP-4 (Huber et al.,
2007) and it is widely used a carbonic anhydrase inhibitor at
1 mM. On the other hand, no direct effect of TEA has been
reported, to our knowledge, on carbonic anhydrase. There-
fore, the common effect of TEA and AZA on S100B secretion
does not likely involve anhydrase carbonic inhibition. On the
contrary, an antagonism between these compounds has been
reported: high levels of TEA (at 500 mM, therefore acting on Kþ
channels) were able to inhibit AZA-induced vasodilatation
(Pickkers et al., 2001). Together, the effects of TEA and AZA
indicate a putative inhibition of AQP-4 under our conditions.
We cannot rule out that other targets of these compounds are
involved in the secretion of S100B. Nevertheless, both TEAand AZA, at concentrations used for AQP-4 inhibition (at
10 mM and 1 mM, respectively), stimulated S100B secretion in
hippocampal slices from young rats. It is, therefore, reason-
able to conceive that the TEA and AZA-induced S100B secre-
tion is linked to AQP-4 inhibition.
Interestingly, in agreement with the stimulatory effect on
S100B secretion observed in young rats, the ontogeny of AQP-4,
evaluated by Western blotting, was found to be more elevated
in young rats (15–30 and 60-days old) than in adult rats (90-
days old). This link, observed in vitro, between AQP-4 inhibition
and S100B secretion cannot help to explain the unchanged
levels of serum S100B that we observed in relapsing NMO
patients, where elevated levels of anti-AQP-4 antibodies are
produced (Robinson-Agramonte et al., 2010). However, con-
versely and in agreement with our present data, other studies
found increased levels of cerebrospinal fluid S100B in NMO
disease (e.g. Misu et al., 2009). This discrepancy between
serum and cerebrospinal fluid samples reinforces the idea
that other cell sources of S100B, beyond astrocytes, contribute
to serum S100B (Goncalves et al., 2008, 2010).
Another aspect investigated in this work was the putative
functional association of glial Kþ channel Kir 4.1 with AQP-4.
In fact, the ontogeny of these proteins, investigated here by
Western blotting, reinforces the idea of a close interaction
between them. The idea of a structural and functional
interaction between Kir 4.1 and AQP-4 is supported by some
evidence (see Nagelhus et al., 2004). For example, membrane
co-localization (Nagelhus et al., 1999) and delayed Kþ clear-
ance in transgenic mice exhibiting mislocalization of AQP-4
Fig. 7 – Western blotting for AQP4 and Kir 4.1 in hippocam-
pal slices of 15, 30, 60 and 90-day old rats. Hippocampal
slices from Wistar rats of different ages (15, 30, 45, 60 and
90-days old) were analyzed by Western blotting for AQP-4
(A) and Kir 4.1 (B). Each value is the mean (7standard error)
of 6 independent experiments performed in triplicate.
a Significantly different from 90 post-natal days rats
(po0.05). b Different from 15, 30 and 60 post-natal days rats
(ANOVA followed by the Tukey’s test).
Fig. 8 – Effect of high potassium on S100B secretion in
hippocampal slices of rats from different ages. Hippocampal
slices from Wistar rats of different ages (15, 30, 45, 60 and
90-days old) were exposed to KCl at concentrations of
30 mM for 1 h. S100B was measured by ELISA. Each value is
a mean (7standard error) of 6 independent experiments
performed in triplicate.  Different letters indicate signifi-
cant statistical difference among ages and treatment with
high potassium (two-way ANOVA followed by simple main
effect test if interaction was positive).
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 4 – 2 2 19(Amiry-Moghaddam et al., 2003). However, some controversy
surrounds these findings. For example, no changes in the
electrophysiology of Muller cells were observed in AQP-4
knockout mice (Ruiz-Ederra et al., 2007) and no changes in
water permeability were observed in hippocampal astrocytes
incubated with BaCl2 (Zhang and Verkman, 2008). The inhibi-
tion of Kir 4.1 (by BaCl2), in contrast to the inhibition of AQP-4,
caused a decrease in S100B secretion in hippocampal slices from
young rats. This argues against a functional coupling between
Kir 4.1 and AQP-4. Notice that at high concentrations of BaCl2
(1mM) the inhibition of S100B secretion was predominant over
the TEA stimulatory effect.
Assuming acute S100B release as being a warning signal or
a protective factor to neighboring cells, it is difficult to
conceive that an impairment of Kir channels results in a
decrease of S100B. In fact, the inhibition of two important
astrocyte activities such as glutamate transport and gap
junctions resulted in S100B release (Leite et al., 2009;
Tramontina et al., 2006). Moreover, Kir inhibition by BaCl2 is
accompanied by a reduction of glutamate uptake
(Kucheryavykh et al., 2007), and glutamate uptake was
reduced in Kir 4.1 knockout mice (Djukic et al., 2007). These
data, together, could suggest that Kir inhibition may result in
an increase in S100B release. In addition, our findings
demonstrate that inhibition of aquaporin-4, whichfunctionally interacts with gap junctions and Kir channels
(Lichter-Konecki et al., 2008), also resulted in increased S100B
release. A possible explanation for this would be that Kir
channel impairment directly affects the mechanism of S100B
secretion, which remains unknown (Leite et al., 2009). Further
experiments will confirm, or not, this possibility. Moreover,
the effect of BaCl2 is not limited to Kir channels and BaCl2
could be affecting S100B secretion, independently of an effect
on Kir channels.
Moreover, it is important to mention that, in two other
conditions that could result from neuronal hyperactivity,
elevated glutamate (e.g. 1 mM) or Kþ (e.g. 30 mM) also leads
to a decrease in S100B release in brain slices (Buyukuysal,
2005; Nardin et al., 2009) which is in agreement with our
results in hippocampal slices of 30 and 90-day old rats
incubated with Kþ high concentration. In support of these
findings, accumulation of Kþ in hippocampal slices after
traumatic brain injury attributed to a decrease in Kir currents
was also observed in control slices incubated with BaCl2
(D’Ambrosio et al., 1999).
Finally, it important to comment that a connection between
astrocyte S100B release and AQP-4 activity could be clinically
useful in the future and could allow the correlation of these
in vitro and in vivo parameters of S100B release, considering
the necessity for the development of therapeutic AQP-4
inhibitors and the current limitations of measurements of
water permeability (Haddoub et al., 2009). Brain disorders
involving fluid imbalances and edema have stimulated the
search for AQP targets and specific inhibitors, which cur-
rently are not available (Yool et al., 2010).
In summary, we show that blockade of AQP-4 with TEA and
AZA (at 10 mM and 1 mM, respectively) in hippocampal slices
from young rats produced an increase in S100B secretion,
compatible with the astroglial activation observed in many
conditions of brain injury. Conversely, inhibition of Kir 4.1
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 1 4 – 2 220channels with BaCl2 (at 100 mM) resulted in a decrease in the
secretion of S100B. Both AQP-4 and Kir 4.1 channels exhibited
a similar ontogenetic profile, in spite of the functional
uncoupling in relation to S100B secretion. These data,
together with other observations from gap junctions and
glutamate transport of astrocytes, contribute to characterize
the operational system involving astroglial activation, parti-
cularly in S100B secretion during conditions of brain injury.4. Experimental procedures
4.1. Animals
Wistar rats were obtained from our breeding colony, main-
tained under controlled light and environmental conditions
(12 h light/12 h dark cycle at a constant temperature of
2271 1C) and had free access to a 20% (w/w) protein com-
mercial chow and water. All animal experiments were carried
out in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH
Publications no. 80-23) revised 1996, following the regulations
of the local animal house authorities.4.2. Material
Polyclonal anti-S100 antibody, polyclonal anti-AQP-4 antibody
and polyclonal anti-Kir 4.1 were purchased from DAKO
(Glostrup, Denmark), Chemicon (Temecula, USA) and Santa
Cruz Biotechnology (Santa Cruz, USA) respectively. The anti-
bodies peroxidase-conjugated IgGs were obtained from
Amersham (Buckingamshire, UK), Alexa fluor (568) and Alexa
fluor (488) were purchased from Invitrogen (Carlsbad, USA).
Monoclonal anti-S100B antibody (SH-B1), 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid, [3(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide] (MTT) and o-phe-
nylenediamine were purchased from Sigma (St. Louis, USA).
Tetraethylammonium chloride (TEA) and barium chloride
(BaCl2) were obtained from Merck (Whitehouse Station,
USA), acetazolamide (AZA) from Alfa-aesar (Ward Hill, USA)
and KCl from Vetec (Duque de Caxias, Brasil).4.3. Preparation of hippocampal slices
Wistar rats (15, 30, 45, 60 and 90 days-old) were killed by
decapitation, the brains were removed and placed in cold
saline medium with the following composition (in mM): 120
NaCl; 2 KCl; 1 CaCl2; 1 MgSO4; 25 HEPES; 1 KH2PO4 and 10
glucose, adjusted to pH 7.4 and previously aerated with O2.
The hippocampi were dissected and transverse slices of
0.3 mm were obtained using a McIlwain Tissue Chopper.
Slices were then transferred immediately into 24-well culture
plates, each well containing 0.3 mL of physiological medium
and only one slice. The medium was changed every 15 min
with fresh saline medium at room temperature. Following a
120 min equilibration period, slices were incubated in med-
ium containing TEA, BaCl2, AZA or KCl 30 mM, as indicated in
the results for 1 h at 30 1C.4.4. Western blotting
Equal amounts (20 mg) of proteins from each sample were
boiled in sample buffer (0.0625 M Tris–HCl, pH 6.8, 2% (w/v)
SDS, 5% (w/v) b-mercaptoethanol, 10% (v/v) glycerol, 0.002%
(w/v) bromophenol blue) and electrophoresed in 10% (w/v)
SDS-polyacrylamide gel. The separated proteins were blotted
onto a nitrocellulose membrane. Equal loading of each
sample was confirmed with Ponceau S staining (Sigma)
(De Souza et al., 2009). Anti-AQP-4 (Chemicon) or anti-Kir
4.1 (Santa Cruz Biotechnology) were used at a dilution of
1:1000. After incubating with the primary antibody for 1 h at
room temperature, filters were washed and incubated with
peroxidase-conjugated anti-rabbit immunoglobulin (IgG) or
peroxidase-conjugated anti-goat immunoglobulin (IgG) at a
dilution of 1:2000. The chemiluminescence signal was
detected using an ECL kit from Amersham.4.5. ELISA for S100B
The S100B concentration was determined in the incubation
medium of slices at 1 h. The ELISA for S100B was carried out, as
described previously (Leite et al., 2008). Briefly, 50 mL of sample
plus 50 mL of Tris buffer were incubated for 2 h on a microtiter
plate previously coated with monoclonal anti-S100B. Polyclonal
anti-S100 was incubated for 30min and then peroxidase-
conjugated anti-rabbit antibody was added for a further
30min. The color reaction with o-phenylenediamine was mea-
sured at 492 nm. The standard S100B curve ranged from 0.002
to 1 ng/mL.4.6. Immunohistochemistry for AQP4 and Kir 4.1
Rats were anesthetized using ketamine/xylazine and were
perfused through the left cardiac ventricle with 200mL of
saline solution, followed by 200mL of 4% paraformaldehyde
in 0.1 M phosphate buffer, pH 7.4. The brains were removed and
left for post-fixation in the same fixative solution at 4 1C for 2 h.
After this, the material was cryoprotected by immersing the
brain in 30% sucrose in phosphate buffer at 4 1C (Rodrigues
et al., 2009). The brains were sectioned (50 mm) on a cryostat
(Leitz) and sections were then pre-incubated in 2% bovine
serum albumin in phosphate buffered saline containing 0.3%
Triton X-100 for 30min. The sections were incubated with
polyclonal anti-AQP4 from rabbit, diluted 1:300 in 2% bovine
serum albumin in phosphate buffer-Triton X-100, for 48 h at
room temperature. After washing several times, tissue sections
were incubated with polyclonal anti-Kir 4.1 from goat, diluted
1:300 for 48 h. Subsequently, an Alexa fluor (568) secondary
antibody, diluted 1:200 in phosphate buffer was incubated at
room temperature for 2 h and then Alexa fluor (488) for a
further 2 h. Afterwards, the sections were mounted on slides
with Fluor save and covered with coverslips. Immunoreactions
for AQP-4 and Kir 4.1 in the stratum radiatum of the CA1
hippocampal region (identified based on intraural coordinates
5.86 to 4.16mm, bregma 3.14 to 4.16mm) (Paxinos and
Watson, 1998) were observed.
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Extracellular S100B content was referred to as ‘‘secretion’’,
based on the cell integrity measurement (data not shown), by
measuring lactate dehydrogenase (LDH) activity with a col-
orimetric commercial kit (from Doles, Brazil) and the colori-
metric MTT method (Hansen et al., 1989).
4.8. Statistical analysis
Data from the experiments are presented as means7stan-
dard error and was analyzed statistically by one-way analysis
of variance (ANOVA) followed by posthoc analyzes (Tukey’s
test) or by two-way analysis of variance followed by simple
main effect test if interaction was positive when indicated.
Results from control conditions (0.01% dimethyl sulfoxide)
used in the figures were not different from those obtained
under basal conditions without dimethyl sulfoxide. Values of
po0.05 were considered to be significant. All analyses were
carried out using the Statistical Package for Social Sciences
(SPSS) software.Acknowledgments
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